Structure–activity relationship study of syringolin A as a potential anticancer agent
作者:Takuya Chiba、Akira Matsuda、Satoshi Ichikawa
DOI:10.1016/j.bmcl.2015.06.015
日期:2015.11
A detailed structure–activity relationship of syringolin A (1), which is a promising antitumor natural product, was described. We previously developed syringolin A analog 2 as a potent proteasome inhibitor by the structure-based drug design of syringolin A. In this Letter, we synthesized a range of analogs of 2, having a different length of the lipophilic chain and substituted aryl group, and their
详细描述了丁香脂素A(1)的结构与活性之间的关系,紫丁香酚A是一种很有前途的抗肿瘤天然产物。我们先前通过丁香酚A的基于结构的药物设计,开发了丁香酚A的类似物2作为有效的蛋白酶体抑制剂。在这封信中,我们合成了一系列2的类似物,它们具有不同的亲脂性链长和取代的芳基,并且评估了它们对人类癌细胞的细胞毒性。事实证明,这些修饰极大地影响了细胞毒性。进一步的优化将导致开发新型的蛋白酶体抑制剂。